Default mode network as a potential biomarker of chemotherapy-related brain injury

Neurobiology of Aging

Volumn 35, Issue SUPPL.2, 2014, Pages

  Kesler, Shelli R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Brain; Chemotherapy; Cognitive decline; Default mode network; Neuroimaging; Resting state fMRI

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

AGING; BRAIN INJURY; BRAIN REGION; BRAIN SIZE; BREAST CANCER; CANCER CHEMOTHERAPY; DEFAULT MODE NETWORK; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; FUNCTIONAL ANATOMY; GRAY MATTER; HIPPOCAMPUS; HUMAN; MENTAL CAPACITY; MENTAL DETERIORATION; MENTAL TASK; NEUROMODULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; WHITE MATTER; CONNECTOME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; NERVOUS SYSTEM INFLAMMATION; TASK PERFORMANCE; BRAIN; CHEMICALLY INDUCED; COGNITION DISORDERS; DRUG EFFECTS; INFLAMMATION; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGING; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; NERVE NET; OXIDATIVE STRESS;

EID: 84903727243     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.03.036     Document Type: Review

References (133)

1. Abraham A. The world according to me: personal relevance and the medial prefrontal cortex. Front. Hum. Neurosci. 2013, 7:341.
2. Achard S., Salvador R., Whitcher B., Suckling J., Bullmore E. Aresilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J.Neurosci. 2006, 26:63-72.
3. Agnati L.F., Guidolin D., Battistin L., Pagnoni G., Fuxe K. The neurobiology of imagination: possible role of interaction-dominant dynamics and default mode network. Front. Psychol. 2013, 4:296.
4. Ahles T.A. Brain vulnerability to chemotherapy toxicities. Psychooncology 2012, 21:1141-1148.
5. Ahles T.A., Saykin A.J. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat. Rev. Cancer 2007, 7:192-201.
6. Ahles T.A., Saykin A.J., McDonald B.C., Li Y., Furstenberg C.T., Hanscom B.S., Mulrooney T.J., Schwartz G.N., Kaufman P.A. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J.Clin. Oncol. 2010, 28:4434-4440.
7. Ahles T.A., Saykin A.J., Noll W.W., Furstenberg C.T., Guerin S., Cole B., Mott L.A. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 2003, 12:612-619.
8. Alexander-Bloch A., Giedd J.N., Bullmore E. Imaging structural co-variance between human brain regions. Nat. Rev. Neurosci. 2013, 14:322-336.
9. Armstrong R.A. The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis". Int. J. Alzheimer's Dis. 2011, 2011:630865.
10. Bartolomei F., Bosma I., Klein M., Baayen J.C., Reijneveld J.C., Postma T.J., Heimans J.J., van Dijk B.W., de Munck J.C., de Jongh A., Cover K.S., Stam C.J. Disturbed functional connectivity in brain tumour patients: evaluation by graph analysis of synchronization matrices. Clin. Neurophysiol. 2006, 117:2039-2049.
11. Baudino, B., D'Agata, F., Castellano, G., Caroppo, P., Cauda, S., Parente, A., Manfredi, M., Geda, E., Orsi, L., Cauda, F., Castelli, L., Sacco, K., Ardito, R., Torta, R., Bisi, G. 2011. Chemotherapy effects on brain glucose metabolism at rest. Nat. Precedings. http://dx.doi.org/hdl:10101/npre.2011.5637.1.
12. Baxter N.N., Durham S.B., Phillips K.A., Habermann E.B., Virning B.A. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy. J.Am. Geriatr. Soc. 2009, 57:403-411.
13. Behzadi Y., Restom K., Liau J., Liu T.T. Acomponent based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 2007, 37:90-101.
14. Benjamin C., Lieberman D.A., Chang M., Ofen N., Whitfield-Gabrieli S., Gabrieli J.D., Gaab N. The influence of rest period instructions on the default mode network. Front. Hum. Neurosci. 2010, 4:218.
15. Bero A.W., Yan P., Roh J.H., Cirrito J.R., Stewart F.R., Raichle M.E., Lee J.M., Holtzman D.M. Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat. Neurosci. 2011, 14:750-756.
16. Blennow K., Hardy J., Zetterberg H. The neuropathology and neurobiology of traumatic brain injury. Neuron 2012, 76:886-899.
17. Bosma I., Reijneveld J.C., Klein M., Douw L., van Dijk B.W., Heimans J.J., Stam C.J. Disturbed functional brain networks and neurocognitive function in low-grade glioma patients: a graph theoretical analysis of resting-state MEG. Nonlinear Biomed. Phys. 2009, 3:9.
18. Boubela R.N., Kalcher K., Huf W., Kronnerwetter C., Filzmoser P., Moser E. Beyond noise: using temporal ICA to extract meaningful information from high-frequency fMRI signal fluctuations during rest. Front. Hum. Neurosci. 2013, 7:168.
19. Bruno J., Hosseini S.M., Kesler S. Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol. Dis. 2012, 48:329-338.
20. Buckner R.L., Andrews-Hanna J.R., Schacter D.L. The brain's default network: anatomy, function, and relevance to disease. Ann. N.Y Acad. Sci. 2008, 1124:1-38.
21. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., Sheline Y.I., Klunk W.E., Mathis C.A., Morris J.C., Mintun M.A. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J.Neurosci. 2005, 25:7709-7717.
22. Bullmore E., Sporns O. The economy of brain network organization. Nat. Rev. Neurosci. 2012, 13:336-349.
23. Cai Z., Zhao B., Ratka A. Oxidative stress and beta-amyloid protein in Alzheimer's disease. Neuromolecular Med. 2011, 13:223-250.
24. Calhoun V.D., Adali T. Multisubject independent component analysis of fMRI: a decade of intrinsic networks, default mode, and neurodiagnostic discovery. IEEE Rev. Biomed. Eng. 2012, 5:60-73.
25. Calhoun V.D., Liu J., Adali T. Areview of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data. Neuroimage 2009, 45(1 Suppl):S163-S172.
26. Chang C., Glover G.H. Effects of model-based physiological noise correction on default mode network anti-correlations and correlations. Neuroimage 2009, 47:1448-1459.
27. Chen J.L., Ros T., Gruzelier J.H. Dynamic changes of ICA-derived EEG functional connectivity in the resting state. Hum. Brain Mapp. 2013, 34:852-868.
28. Cole D.M., Smith S.M., Beckmann C.F. Advances and pitfalls in the analysis and interpretation of resting-state FMRI data. Front. Syst. Neurosci. 2010, 4:8.
29. Cole M.W., Pathak S., Schneider W. Identifying the brain's most globally connected regions. Neuroimage 2010, 49:3132-3148.
30. Conroy S.K., McDonald B.C., Ahles T.A., West J.D., Saykin A.J. Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates. Brain Imaging Behav. 2013, 7:491-500.
31. Conroy S.K., McDonald B.C., Smith D.J., Moser L.R., West J.D., Kamendulis L.M., Klaunig J.E., Champion V.L., Unverzagt F.W., Saykin A.J. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Res. Treat 2013, 137:493-502.
32. Craddock R.C., Holtzheimer P.E., Hu X.P., Mayberg H.S. Disease state prediction from resting state functional connectivity. Magn. Reson. Med. 2009, 62:1619-1628.
33. Damoiseaux J.S. Resting-state fMRI as a biomarker for Alzheimer's disease?. Alzheimer's Res. Ther. 2012, 4:8.
34. Damoiseaux J.S., Prater K.E., Miller B.L., Greicius M.D. Functional connectivity tracks clinical deterioration in Alzheimer's disease. Neurobiol. Aging 2012, 33:828.e19-828.e30.
35. Damoiseaux J.S., Rombouts S.A., Barkhof F., Scheltens P., Stam C.J., Smith S.M., Beckmann C.F. Consistent resting-state networks across healthy subjects. Proc. Natl. Acad. Sci. U.S.A 2006, 103:13848-13853.
36. de Ruiter M.B., Reneman L., Boogerd W., Veltman D.J., van Dam F.S., Nederveen A.J., Boven E., Schagen S.B. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum. Brain Mapp. 2011, 32:1206-1219.
37. de Ruiter M.B., Schagen S.B. Functional MRI studies in non-CNS cancers. Brain Imaging Behav. 2013, 7:388-408.
38. Deprez S., Billiet T., Sunaert S., Leemans A. Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review. Brain Imaging Behav. 2013, 7:409-435.
39. Di X., Biswal B.B. Metabolic brain covariant networks as revealed by FDG-PET with reference to resting-state fMRI networks. Brain Connect. 2012, 2:275-283. Alzheimer's Disease Neuroimaging, I.
40. Du X.L., Xia R., Hardy D. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort. Am. J. Clin. Oncol. 2010, 33:533-543.
41. Dumas J.A., Makarewicz J., Schaubhut G.J., Devins R., Albert K., Dittus K., Newhouse P.A. Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging Behav. 2013, 7:524-532.
42. Duncan N.W., Northoff G. Overview of potential procedural and participant-related confounds for neuroimaging of the resting state. J.Psychiatry Neurosci. 2013, 38:84-96.
43. Fair D.A., Schlaggar B.L., Cohen A.L., Miezin F.M., Dosenbach N.U., Wenger K.K., Fox M.D., Snyder A.Z., Raichle M.E., Petersen S.E. Amethod for using blocked and event-related fMRI data to study "resting state" functional connectivity. Neuroimage 2007, 35:396-405.
44. Fox M.D., Greicius M. Clinical applications of resting state functional connectivity. Front. Syst. Neurosci. 2010, 4:19.
45. Fox M.D., Snyder A.Z., Vincent J.L., Corbetta M., Van Essen D.C., Raichle M.E. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc. Natl. Acad. Sci. U.S.A 2005, 102:9673-9678.
46. Fox M.D., Snyder A.Z., Zacks J.M., Raichle M.E. Coherent spontaneous activity accounts for trial-to-trial variability in human evoked brain responses. Nat. Neurosci. 2006, 9:23-25.
47. Ganz P.A., Bower J.E., Kwan L., Castellon S.A., Silverman D.H.S., Geist C., Breen E.C., Irwin M.R., Cole S.W. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?. Brain Behav. Immun. 2013, 30:S99-S108.
48. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Reiss A.L., Schatzberg A.F. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol. Psychiatry 2007, 62:429-437.
49. Greicius M.D., Srivastava G., Reiss A.L., Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl. Acad. Sci. U.S.A 2004, 101:4637-4642.
50. Gupta S.K., Lamont E.B. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J.Am. Geriatr. Soc. 2004, 52:1681-1687.
51. He Y., Chen Z., Evans A. Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease. J.Neurosci. 2008, 28:4756-4766.
52. Heck J.E., Albert S.M., Franco R., Gorin S.S. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy. J.Am. Geriatr. Soc. 2008, 56:1687-1692.
53. Heimans J.J., Reijneveld J.C. Factors affecting the cerebral network in brain tumor patients. J.Neurooncol. 2012, 108:231-237.
54. Herrup K. Reimagining Alzheimer's disease-an age-based hypothesis. J.Neurosci. 2010, 30:16755-16762.
55. Hogervorst E. Effects of gonadal hormones on cognitive behavior in elderly men and women. J.Neuroendocrinol. 2013, 25:1182-1195.
56. Hosseini S.M., Hoeft F., Kesler S.R. GAT: a graph-theoretical analysis toolbox for analyzing between-group differences in large-scale structural and functional brain networks. PLoS One 2012, 7:e40709.
57. Hosseini S.M., Kesler S.R. Comparing connectivity pattern and small-world organization between structural correlation and resting-state networks in healthy adults. Neuroimage 2013, 78:402-414.
58. Hosseini S.M., Kesler S.R. Influence of choice of null network on small-world parameters of structural correlation networks. PLoS One 2013, 8:e67354.
59. Hosseini S.M., Kesler S.R. Multivariate pattern analysis of fMRI in breast cancer survivors and healthy women. J.Int. Neuropsychol. Soc. 2013, 19:1-11.
60. Hosseini S.M., Koovakkattu D., Kesler S.R. Altered small-world properties of gray matter networks in breast cancer. BMC Neurol. 2012, 12:28.
61. Howlader N., Noone A., Krapcho M., Garshell J., Neyman N., Altekruse S., Kosary C., Yu M., Ruhl J., Tatalovich Z., Cho H., Mariotto A., Lewis D., Chen H., Feuer E., Cronin K. SEER Cancer Statistics Review, 1975-2010 2013, National Cancer Institute, Available at: http://www.seer.cancer.gov/csr/1975_2011/.
62. Hutchison R.M., Womelsdorf T., Allen E.A., Bandettini P.A., Calhoun V.D., Corbetta M., Della Penna S., Duyn J.H., Glover G.H., Gonzalez-Castillo J., Handwerker D.A., Keilholz S., Kiviniemi V., Leopold D.A., de Pasquale F., Sporns O., Walter M., Chang C. Dynamic functional connectivity: promise, issues, and interpretations. Neuroimage 2013, 80:360-378.
63. Kaiser J., Bledowski C., Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex 2014, 54:33-50.
64. Kamitani Y., Tong F. Decoding the visual and subjective contents of the human brain. Nat. Neurosci. 2005, 8:679-685.
65. Kapogiannis D., Mattson M.P. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol 2011, 10:187-198.
66. Kesler S., Janelsins M., Koovakkattu D., Palesh O., Mustian K., Morrow G., Dhabhar F.S. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav. Immun. 2013, 30(Suppl):S109-S116.
67. Kesler S.R., Bennett F.C., Mahaffey M.L., Spiegel D. Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin. Cancer Res. 2009, 15:6665-6673.
68. Kesler S.R., Kent J.S., O'Hara R. Prefrontal cortex and executive function impairments in primary breast cancer. Arch. Neurol. 2011, 68:1447-1453.
69. Kesler S.R., Watson C., Koovakkattu D., Lee C., O'Hara R., Mahaffey M.L., Wefel J.S. Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy. Brain Imaging Behav. 2013, 7:501-510.
70. Kesler S.R., Wefel J.S., Hosseini S.M., Cheung M., Watson C.L., Hoeft F. Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc. Natl. Acad. Sci. U.S.A 2013, 110:11600-11605.
71. Koppelmans V., Breteler M.M., Boogerd W., Seynaeve C., Schagen S.B. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia. Crit. Rev. Oncol. Hematol. 2013, 88:87-101.
72. Koppelmans V., de Ruiter M.B., van der Lijn F., Boogerd W., Seynaeve C., van der Lugt A., Vrooman H., Niessen W.J., Breteler M.M., Schagen S.B. Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res. Treat 2012, 132:1099-1106.
73. Kravitz E., Schmeidler J., Beeri M.S. Cognitive decline and dementia in the oldest-old. Rambam Maimonides Med. J. 2012, 3:e0026.
74. Laird A.R., Eickhoff S.B., Fox P.M., Uecker A.M., Ray K.L., Saenz J.J., McKay D.R., Bzdok D., Laird R.W., Robinson J.L., Turner J.A., Turkeltaub P.E., Lancaster J.L., Fox P.T. The BrainMap strategy for standardization, sharing, and meta-analysis of neuroimaging data. BMC Res. Notes 2011, 4:349.
75. LaViolette P., Collier W., Schmainda K.M., Piacentine L., Douville K.L., Chitambar C.R., Tran A., Claesges S.A., Durgerian S.J., Bloom A.S. Functional Connectivity and Arterial Spin Labeling in Chemotherapy Induced Cognitive Impairment ("Chemobrain") 2009, International Society for Magnetic Resonance Medicine (ISMRM), Honolulu, HI, USA. http://cds.ismrm.org/protected/09MProceedings/files/02231.pdf.
76. Liu D., Dong Z., Zuo X., Wang J., Zang Y. Eyes-open/eyes-closed dataset sharing for reproducibility evaluation of resting state fMRI data analysis methods. Neuroinformatics 2013, 11:469-476.
77. Lopez Zunini R.A., Scherling C., Wallis N., Collins B., Mackenzie J., Bielajew C., Smith A.M. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study. Brain Imaging Behav. 2012, 7:460-477.
78. Lord L.D., Expert P., Huckins J.F., Turkheimer F.E. Cerebral energy metabolism and the brain's functional network architecture: an integrative review. J.Cereb. Blood Flow Metab. 2013, 33:1347-1354.
79. Lynch M.A. Age-related neuroinflammatory changes negatively impact on neuronal function. Front. Aging Neurosci. 2010, 1:6.
80. Mahmoudi A., Takerkart S., Regragui F., Boussaoud D., Brovelli A. Multivoxel pattern analysis for FMRI data: a review. Comput. Math. Methods Med. 2012, 2012:961257.
81. Mandelblatt J.S., Hurria A., McDonald B.C., Saykin A.J., Stern R.A., VanMeter J.W., McGuckin M., Traina T., Denduluri N., Turner S., Howard D., Jacobsen P.B., Ahles T. Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?. Semin. Oncol. 2013, 40:709-725. Thinking, Living With Cancer, S.
82. Margulies D.S., Bottger J., Long X., Lv Y., Kelly C., Schafer A., Goldhahn D., Abbushi A., Milham M.P., Lohmann G., Villringer A. Resting developments: a review of fMRI post-processing methodologies for spontaneous brain activity. MAGMA 2010, 23:289-307.
83. McDonald B.C., Conroy S.K., Ahles T.A., West J.D., Saykin A.J. Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J.Clin. Oncol. 2012, 30:2500-2508.
84. McDonald B.C., Saykin A.J. Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations. Brain Imaging Behav. 2013, 7:374-387.
85. Miller A.H., Ancoli-Israel S., Bower J.E., Capuron L., Irwin M.R. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J.Clin. Oncol. 2008, 26:971-982.
86. Minzenberg M.J., Yoon J.H., Carter C.S. Modafinil modulation of the default mode network. Psychopharmacology (Berl) 2011, 215:23-31.
87. Monje M., Dietrich J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav. Brain Res. 2012, 227:376-379.
88. Newton A.T., Morgan V.L., Rogers B.P., Gore J.C. Modulation of steady state functional connectivity in the default mode and working memory networks by cognitive load. Hum. Brain Mapp. 2011, 32:1649-1659.
89. Northoff G., Qin P., Nakao T. Rest-stimulus interaction in the brain: a review. Trends Neurosci. 2010, 33:277-284.
90. O'Shaughnessy J.A. Chemotherapy-induced cognitive dysfunction: a clearer picture. Clin. Breast Cancer 2003, 4(Suppl. 2):S89-S94.
91. Orru G., Pettersson-Yeo W., Marquand A.F., Sartori G., Mechelli A. UsingSupport Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci. Biobehav Rev. 2012, 36:1140-1152.
92. Pomykala K.L., de Ruiter M.B., Deprez S., McDonald B.C., Silverman D.H. Integrating imaging findings in evaluating the post-chemotherapy brain. Brain Imaging Behav. 2013, 7:436-452.
93. Pomykala K.L., Ganz P.A., Bower J.E., Kwan L., Castellon S.A., Mallam S., Cheng I., Ahn R., Breen E.C., Irwin M.R., Silverman D.H. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav. 2013, 7:511-523.
94. Qin P., Northoff G. How is our self related to midline regions and the default-mode network?. Neuroimage 2011, 57:1221-1233.
95. Raichle M.E. The restless brain. Brain Connect. 2011, 1:3-12.
96. Raichle M.E., Mintun M.A. Brain work and brain imaging. Annu. Rev. Neurosci. 2006, 29:449-476.
97. Raji M.A., Tamborello L.P., Kuo Y.F., Ju H., Freeman J.L., Zhang D.D., Giordano S.H., Goodwin J.S. Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer. Med. Oncol. 2009, 26:452-459.
98. Rubinov M., McIntosh A.R., Valenzuela M.J., Breakspear M. Simulation of neuronal death and network recovery in a computational model of distributed cortical activity. Am. J. Geriatr. Psychiatry 2009, 17:210-217.
99. Sambataro F., Murty V.P., Callicott J.H., Tan H.Y., Das S., Weinberger D.R., Mattay V.S. Age-related alterations in default mode network: impact on working memory performance. Neurobiol. Aging 2010, 31:839-852.
100. Sasai S., Homae F., Watanabe H., Sasaki A.T., Tanabe H.C., Sadato N., Taga G. ANIRS-fMRI study of resting state network. Neuroimage 2012, 63:179-193.
101. Scherling C.S., Smith A. Opening up the window into "chemobrain": a neuroimaging review. Sensors 2013, 13:3169-3203.
102. Seigers R., Timmermans J., van der Horn H.J., de Vries E.F., Dierckx R.A., Visser L., Schagen S.B., van Dam F.S., Koolhaas J.M., Buwalda B. Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav. Brain Res. 2010, 207:265-272.
103. Sheline Y.I., Raichle M.E., Snyder A.Z., Morris J.C., Head D., Wang S., Mintun M.A. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol. Psychiatry 2010, 67:584-587.
104. Shen X., Tokoglu F., Papademetris X., Constable R.T. Groupwise whole-brain parcellation from resting-state fMRI data for network node identification. Neuroimage 2013, 82:403-415.
105. Shirer W.R., Ryali S., Rykhlevskaia E., Menon V., Greicius M.D. Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cereb. Cortex 2011, 22:158-165.
106. Silverman D.H., Dy C.J., Castellon S.A., Lai J., Pio B.S., Abraham L., Waddell K., Petersen L., Phelps M.E., Ganz P.A. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res. Treat 2007, 103:303-311.
107. Simo M., Rifa-Ros X., Rodriguez-Fornells A., Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci. Biobehav. Rev. 2013, 37:1311-1321.
108. Smith S.M., Fox P.T., Miller K.L., Glahn D.C., Fox P.M., Mackay C.E., Filippini N., Watkins K.E., Toro R., Laird A.R., Beckmann C.F. Correspondence of the brain's functional architecture during activation and rest. Proc. Natl. Acad. Sci. U.S.A 2009, 106:13040-13045.
109. Sporns O. The human connectome: a complex network. Ann. N.Y Acad. Sci. 2011, 1224:109-125.
110. Steffener J., Stern Y. Exploring the neural basis of cognitive reserve in aging. Biochim. Biophys. Acta 2012, 1822:467-473.
111. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012, 11:1006-1012.
112. Stevens A.A., Tappon S.C., Garg A., Fair D.A. Functional brain network modularity captures inter- and intra-individual variation in working memory capacity. PLoS One 2012, 7:e30468.
113. Storti S.F., Formaggio E., Nordio R., Manganotti P., Fiaschi A., Bertoldo A., Toffolo G.M. Automatic selection of resting-state networks with functional magnetic resonance imaging. Front. Neurosci. 2013, 7:72.
114. Takeuchi H., Taki Y., Hashizume H., Sassa Y., Nagase T., Nouchi R., Kawashima R. The association between resting functional connectivity and creativity. Cereb. Cortex 2012, 22:2921-2929.
115. Takeuchi H., Taki Y., Nouchi R., Hashizume H., Sekiguchi A., Kotozaki Y., Nakagawa S., Miyauchi C.M., Sassa Y., Kawashima R. Effects of working memory training on functional connectivity and cerebral blood flow during rest. Cortex 2013, 49:2106-2125.
116. Van Dijk K.R., Hedden T., Venkataraman A., Evans K.C., Lazar S.W., Buckner R.L. Intrinsic functional connectivity as a tool for human connectomics: theory, properties, and optimization. J.Neurophysiol. 2010, 103:297-321.
117. van Wijk B.C.M., Stam C.J., Daffertshofer A. Comparing brain networks of different size and connectivity density using graph theory. PLoS One 2010, 5:e13701.
118. Vardy J.L., Booth C., Pond G.R., Zhang H., Galica J., Dhillon H., Clarke S.J., Tannock I.F. Cytokine levels in patients (pts) with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function. J.Clin. Oncol. (meeting Abstracts) 2007, 25(18_suppl):9070.
119. Verghese P.B., Castellano J.M., Garai K., Wang Y., Jiang H., Shah A., Bu G., Frieden C., Holtzman D.M. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc. Natl. Acad. Sci. U.S.A 2013, 110:E1807-E1816.
120. Voss M.W., Prakash R.S., Erickson K.I., Basak C., Chaddock L., Kim J.S., Alves H., Heo S., Szabo A.N., White S.M., Wojcicki T.R., Mailey E.L., Gothe N., Olson E.A., McAuley E., Kramer A.F. Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front. Aging Neurosci. 2010, 2.
121. Waites A.B., Stanislavsky A., Abbott D.F., Jackson G.D. Effect of prior cognitive state on resting state networks measured with functional connectivity. Hum. Brain Mapp. 2005, 24:59-68.
122. Wang Z., Peterson B.S. Partner-matching for the automated identification of reproducible ICA components from fMRI datasets: algorithm and validation. Hum. Brain Mapp. 2008, 29:875-893.
123. Wefel J.S., Saleeba A.K., Buzdar A.U., Meyers C.A. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 2010, 116:3348-3356.
124. Wefel J.S., Schagen S.B. Chemotherapy-related cognitive dysfunction. Curr. Neurol. Neurosci. Rep. 2012, 12:267-275.
125. Wefel J.S., Vardy J., Ahles T., Schagen S.B. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011, 12:703-708.
126. Whalley L.J., Deary I.J., Appleton C.L., Starr J.M. Cognitive reserve and the neurobiology of cognitive aging. Ageing Res. Rev. 2004, 3:369-382.
127. Whitfield-Gabrieli S., Ford J.M. Default mode network activity and connectivity in psychopathology. Annu. Rev. Clin. Psychol. 2012, 8:49-76.
128. Whitlow C.T., Casanova R., Maldjian J.A. Effect of resting-state functional MR imaging duration on stability of graph theory metrics of brain network connectivity. Radiology 2011, 259:516-524.
129. Wu K., Taki Y., Sato K., Qi H., Kawashima R., Fukuda H. Alongitudinal study of structural brain network changes with normal aging. Front. Hum. Neurosci. 2013, 7:113.
130. Yan F.X., Wu C.W., Cheng S.Y., Lim K.E., Hsu Y.Y., Liu H.L. Resting-state functional magnetic resonance imaging analysis with seed definition constrained by regional homogeneity. Brain Connect. 2013, 3:438-449.
131. Yang L., Lin F., Zhou Y., Xu J., Yu C., Pan W.J., Lei H. Iterative cross-correlation analysis of resting state functional magnetic resonance imaging data. PLoS One 2013, 8:e58653.
132. Yao J., Rettberg J.R., Klosinski L.P., Cadenas E., Brinton R.D. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Mol. Aspects Med 2011, 32:247-257.
133. Zhang D., Raichle M.E. Disease and the brain's dark energy. Nat. Rev. Neurol. 2010, 6:15-28.